Trastuzumab, not lapatinib, has therapeutic effects on Chinese patients with HER2-positive cholangiocarcinoma

Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):477-479. doi: 10.1016/j.hbpd.2018.09.011. Epub 2018 Sep 15.

¹ Department of Medical Oncology, Shulan (Hangzhou) Hospital, Hangzhou 310022, China. Electronic address: [email protected].
² Department of Medical Oncology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
³ OrigiMed, Shanghai, China.
⁴ OrigiMed, Shanghai, China; Center of Precision Medicine, Shulan (Hangzhou) Hospital, Hangzhou 310022, China.
⁵ Department of Bone Marrow, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

No abstract available

Publication types